Expert Analysis

How State FCA Activity May Affect Civil Fraud Enforcement

A growing trend of state attorneys general enforcing their False Claims Act analogues independently of the U.S. De... (more story)

Wage-Based H-1B Rule Amplifies Lottery Risks For Law Firms

Under the wage-based H-1B lottery rule taking effect Feb. 27, law firms planning to hire noncitizen law graduates ... (more story)

Assessing Compliance Risks Around TrumpRx Participation

As there are novel compliance obligations and potential political opposition related to the new TrumpRx online dru... (more story)

Deals & Corporate Governance More

Olympus Slips Whistleblower Suit Over Testing Practices

A Pennsylvania federal judge has dismissed a whistleblower lawsuit brought by the former head of product development for Olympus Corp. of the Americas, ruling that the ex-executive failed to show he was fired ... (more story)

CareDx Seeks High Court Review Of $45M False Ad Case

Transplant diagnostics company CareDx has asked the U.S. Supreme Court to review a Third Circuit decision that erased a nearly $45 million jury award against rival Natera in a false advertising case, arguing t... (more story)

Ventas, Welltower See Growth Amid Senior Housing Push

Real estate investment trusts Welltower Inc. and Ventas Inc. recorded strong financial results from the last quarter and the full year of 2025, as both companies intensified their focus on senior housing, a se... (more story)

Judge Limits Insurers' Exposure in Opioid Coverage Fight

Insurers garnered several wins Tuesday in a dispute over coverage for thousands of opioid suits against bankrupt pharmaceutical company Endo International, with a Pennsylvania federal court ruling favorably fo... (more story)

5th Circ. Tosses Challenge To La. 340B Discount Drug Rule

A Fifth Circuit panel upheld on Monday a Louisiana law that allows the state to stop prescription drug manufacturers from blocking safety-net healthcare providers from contracting with outside pharmacies to di... (more story)

Paul Weiss, Goodwin Steer Eli Lilly's $2.4B Orna Buy

Pharmaceutical giant Eli Lilly & Co., advised by Paul Weiss Rifkind Wharton & Garrison LLP, on Monday announced that it has agreed to buy Goodwin Procter LLP-led biotechnology firm Orna Therapeutics Inc. in a ... (more story)

Digital Health & Technology More

California's New Privacy Laws Demand Preparation From Cos.

An increase in breach disclosures is coinciding with California's most comprehensive privacy and artificial intelligence legislation taking effect, illustrating the range of vulnerabilities organizations in th... (more story)

'The Shoe Is On The Other Foot': Judge Needles Meta In MDL

A California federal judge presiding over social media addiction multidistrict litigation Wednesday criticized Meta's bid to push newly filed arbitration demands into court, saying she doesn't have jurisdictio... (more story)

NY Judge Rejects Bid To Stop SD Action Against Abortion Ads

A New York federal judge said Wednesday that she can't block South Dakota officials from pursuing state legal action against an abortion rights group that launched an advertising campaign in South Dakota, sayi... (more story)

AI Scientific Discovery Order Implications For Life Sciences

President Donald Trump's November executive order establishing a government effort to use artificial intelligence to accelerate scientific discovery has the potential to leverage significant federal resources ... (more story)

Pa. Health Network Escapes Wiretapping Suit, For Now

A Pennsylvania federal judge has tossed class claims alleging Penn Highlands Healthcare Inc. violated state wiretapping laws by sharing patient health information with Google Analytics, reasoning that the pati... (more story)

Meet The Attys For Novo Nordisk In Hims & Hers GLP-1 Row

Rodger D. Smith II and Jeremy A. Tigan of Morris Nichols Arsht & Tunnell LLP represent Novo Nordisk in its challenge against telehealth company Hims & Hers Health Inc.

Policy & Compliance More

RFK Jr. Taps Ex-Jones Day Atty For FDA Senior Counselor

U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. has named a former Jones Day partner as one of the U.S. Food and Drug Administration's senior counselors, according to an announcement.

States' Generic Drugs Antitrust Case Headed Toward Trial

A Connecticut federal judge has mostly refused to side with pharmaceutical companies facing states' generic drug price-fixing litigation against them, ruling that there are genuine disputes of material fact as... (more story)

Docs Urge Judge To Block CDC's Childhood Vaccine Changes

Doctors organizations Friday urged a Massachusetts federal judge to stop the government from implementing its new, shorter list of recommended vaccines for children and prevent the next meeting of a committee ... (more story)

Iowa AG Urges 8th Circ. To Unblock Parts Of State PBM Law

The state of Iowa urged the Eighth Circuit on Friday to lift a preliminary block on parts of a law limiting pharmacy benefit managers' power to set drug prices in the Hawkeye State, arguing a lower court judge... (more story)

Breast Surgery Patients Want ERISA Class Cert. Rethink

A United Healthcare plan member asked a New Jersey federal judge to rethink her decision denying class certification in a suit alleging the insurer systematically refused to cover postmastectomy breast reconst... (more story)

Trump Admin. Blocked From Cutting $600M In Health Funding

An Illinois federal judge on Thursday temporarily blocked the Trump administration from terminating more than $600 million in public health funding to four Democratic-led states, saying the states will likely ... (more story)